FOXD3 May Be a New Cellular Target Biomarker as a Hypermethylation Gene in Human Ovarian Cancer

Cancer Cell International - United Kingdom
doi 10.1186/s12935-019-0755-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Human Epididymis Protein-4 Gene Expression as a Biomarker in Patients With Ovarian Cancer in Iran

Open Journal of Clinical Diagnostics
2017English

"May Adiponectin Be Considered as a Novel Cardiometabolic Biomarker?"

Journal of Diabetes, Metabolic Disorders & Control
2014English

Epigenetic Aberrant Hypermethylation of DNA in Endometrial Cancer: Application as a Biomarker

Journal of Cancer Therapy
2011English

Cellular Senescence as a Target in Cancer Control

Journal of Aging Research
GerontologyGeriatrics
2011English

BTG1 Might Be Employed as a Biomarker for Carcinogenesis and a Target for Gene Therapy in Colorectal Cancers

Oncotarget
Oncology
2016English

Serum miR‑22 May Be a Biomarker for Papillary Thyroid Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Drug Combo May Be Effective in Ovarian Cancer

Cancer Discovery
Oncology
2014English

Stress-Induced Phosphoprotein 1 as a Secreted Biomarker for Human Ovarian Cancer Promotes Cancer Cell Proliferation

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy